FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to a pharmaceutical composition, which contains formula 
compound as an active pharmaceutical ingredient or its pharmaceutically acceptable salt; and at least pharmaceutically acceptable filler, where the active pharmaceutical ingredient is present in an amount of at least 80% of the total dry weight of the composition.
EFFECT: composition possesses the good rate of release independently on the pH value.
8 cl, 4 dwg, 7 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SIGMA-RECEPTOR INHIBITORS | 2005 |
|
RU2417987C2 |
| 1-ARYL-3-AMINOALKOXYPYRAZOL AS SIGMA LIGANDS INTENSIFYING ANALGESIC ACTION OF OPIOIDS AND RELIEVING ADDICTION THERETO | 2009 |
|
RU2519060C2 |
| USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN | 2012 |
|
RU2608943C2 |
| SIGMA LIGANDS FOR POTENTIATING ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POSTOPERATIVE PAIN AND ATTENUATING DEPENDENCY THEREOF | 2011 |
|
RU2563460C2 |
| USE OF SIGMA LIGANDS FROM PAIN IN BONE CANCER | 2011 |
|
RU2585095C2 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| USE OF SIGMA LIGANDS WITH INDUCED OPIOIDS HYPERALGESIA | 2011 |
|
RU2589899C2 |
| SIGMA-LIGANDS FOR APPLICATION IN PREVENTION AND/OR TREATMENT OF POSTOPERATIVE PAIN | 2011 |
|
RU2569055C2 |
| PYRAZINO[1,2-A]INDOLE COMPOUNDS, PREPARATION AND USE THEREOF IN MEDICAMENTS | 2014 |
|
RU2660417C2 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
